Clinical Trial

The Effect of NAD Supplementation on Brain Vascular Health in Aging

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Daily consumption of one of the forms of Vitamin B3, the Nicotinamide Riboside (NR), energizes the body and combats cellular aging. This study is designed to test whether NR can also improve brain health and memory.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-07-29; most recent amendment 2026-03-26.
Status change: Not Yet Recruiting → Recruiting 2023-05-08
Trial Details
NCT Number NCT05483465
Lead Sponsor University of Oklahoma
Collaborators: University of Pennsylvania, Oklahoma Medical Research Foundation, Elysium Health
Conditions Aging
Enrollment 214 participants
Start Date 2023-05-03
Primary Completion 2027-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-01